The European Federation for Medicinal 91AV and Chemical Biology (EFMC) and the Division of Medicinal 91AV of the Portuguese Chemical Society will be organising the 10th edition of the International Symposium on Advances in Synthetic and Medicinal 91AV (EFMC-ASMC 2025).
This event will take place in Porto, Portugal from August 31-September 4, 2025, and is planned in the series of successful events which started in 2004 in Moscow and most recently took place in 2017 in Vienna, 2019 in Athens and 2023 in Zagreb.
This symposium will bring together chemists from industry, academia and start-up companies from around the world and is focused on the most recent advances in new synthetic methodologies, total synthesis, chemical biology, process and medicinal chemistry, and automation & AI approaches in synthesis and drug discovery.
The general concept of the meeting, with talks equally selected from industry and academia, will include
- an opening lecture
- 26 invited lectures
- 10 oral communications selected from submitted abstracts
A large poster session and commercial exhibition will complete the programme.
The 2025 edition of EFMC-ASMC is chaired by:
- Dr Malin Lemurell (AstraZeneca, Sweden)
- Prof. Nuno Maulide (University of Vienna, Austria)
This event will take place in Porto, Portugal from August 31-September 4, 2025, and is planned in the series of successful events which started in 2004 in Moscow and most recently took place in 2017 in Vienna, 2019 in Athens and 2023 in Zagreb.
This symposium will bring together chemists from industry, academia and start-up companies from around the world and is focused on the most recent advances in new synthetic methodologies, total synthesis, chemical biology, process and medicinal chemistry, and automation & AI approaches in synthesis and drug discovery.
The general concept of the meeting, with talks equally selected from industry and academia, will include
- an opening lecture
- 26 invited lectures
- 10 oral communications selected from submitted abstracts
A large poster session and commercial exhibition will complete the programme.
The 2025 edition of EFMC-ASMC is chaired by:
- Dr Malin Lemurell (AstraZeneca, Sweden)
- Prof. Nuno Maulide (University of Vienna, Austria)
